Cargando…

A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy

BACKGROUND: At present, there is insufficient medical evidence to determine whether adjuvant chemotherapy is necessary for T2N0M0 gastric cancer. AIM: To obtain a risk score to assess the need for adjuvant chemotherapy in patients with T2N0M0 gastric cancer. METHODS: We identified 325 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Quan, Kang, Wen-Zhe, Xiong, Jian-Ping, Shao, Xin-Xin, Li, Wei-Kun, Hu, Hai-Tao, Tian, Yan-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594010/ https://www.ncbi.nlm.nih.gov/pubmed/36304088 http://dx.doi.org/10.3748/wjg.v28.i38.5626

Ejemplares similares

Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection
por: Kang, Wen-Zhe, et al.
Publicado: (2022)

Adjuvant chemotherapy may be unnecessary for ypT0-2N0 gastric cancer patients after neoadjuvant chemotherapy and curative gastrectomy
por: Shao, Xinxin, et al.
Publicado: (2023)

Laparoscopic vs open total gastrectomy for advanced gastric cancer following neoadjuvant therapy: A propensity score matching analysis
por: Hu, Hai-Tao, et al.
Publicado: (2022)

Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer
por: Wang, Qi-Wei, et al.
Publicado: (2018)

Surgical resection of gastric stump cancer following proximal gastrectomy for adenocarcinoma of the esophagogastric junction
por: Ma, Fu-Hai, et al.
Publicado: (2019)

Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
por: Ren, Deng-Feng, et al.
Publicado: (2018)

Survival outcomes and prognostic indicators for gastric cancer patients with positive peritoneal wash cytology but no peritoneal metastasis after radical gastrectomy
por: Kang, Wen-Zhe, et al.
Publicado: (2021)

Feasibility of totally laparoscopic gastrectomy without prophylactic drains in gastric cancer patients
por: Liu, Hao, et al.
Publicado: (2021)

Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer
por: Huang, Hai-Bo, et al.
Publicado: (2020)

Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience
por: Tian, Yan-Tao, et al.
Publicado: (2019)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Feasibility and nutritional impact of laparoscopic assisted tailored subtotal gastrectomy for middle-third gastric cancer
por: Liu, Hao, et al.
Publicado: (2020)

Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T(3-4a)N0M0 Gastric Cancer Patients after D2 Gastrectomy
por: Chen, Shi, et al.
Publicado: (2017)

Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
por: Mei, Yu, et al.
Publicado: (2022)

Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study
por: Li, Yang, et al.
Publicado: (2020)

Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis
por: Zheng, Xiao-Hao, et al.
Publicado: (2019)

Nomograms predicting prognosis of patients with pathological stages T1N2-3 and T3N0 gastric cancer
por: Wang, Yu-Fei, et al.
Publicado: (2022)

Nomogram to predict prolonged postoperative ileus after gastrectomy in gastric cancer
por: Liang, Wen-Quan, et al.
Publicado: (2019)

Could neoadjuvant chemotherapy increase postoperative complication risk of laparoscopic total gastrectomy? A mono-institutional propensity score-matched study in China
por: Cui, Hao, et al.
Publicado: (2021)

Preoperative albumin-bilirubin score is a prognostic factor for gastric cancer patients after curative gastrectomy
por: Szor, Daniel Jose, et al.
Publicado: (2023)

Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer
por: Ma, Shuai, et al.
Publicado: (2021)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Protective effects of female reproductive factors on gastric signet-ring cell carcinoma
por: Li, Yang, et al.
Publicado: (2022)

Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
por: Li, Yi-Fan, et al.
Publicado: (2023)

Can Gastric Cancer Patients with High Mandard Score Benefit from Neoadjuvant Chemotherapy?
por: Kang, Wen-Zhe, et al.
Publicado: (2022)

Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion
por: Jin, Peng, et al.
Publicado: (2021)

Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival
por: Jiang, Zhi-Nong, et al.
Publicado: (2021)

Short and long-term outcomes between laparoscopic and open total gastrectomy for advanced gastric cancer after neoadjuvant chemotherapy
por: Cui, Hao, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy
por: Jin, Ying, et al.
Publicado: (2013)

Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes
por: Liu, Yi, et al.
Publicado: (2018)

Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter study
por: Huang, Ze-Ning, et al.
Publicado: (2019)

Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy
por: Zeng, Ya, et al.
Publicado: (2019)

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022)

Comparison of short-term efficacy between totally laparoscopic gastrectomy and laparoscopic assisted gastrectomy for elderly patients with gastric cancer
por: Zhao, Rui-Yang, et al.
Publicado: (2022)

Effects of age on survival and morbidity in gastric cancer patients undergoing gastrectomy
por: Fujiwara, Yoshinori, et al.
Publicado: (2017)

Optimal proximal resection margin distance for gastrectomy in advanced gastric cancer
por: Kim, Amy, et al.
Publicado: (2020)

Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer
por: Bao, Huizheng, et al.
Publicado: (2017)

Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer
por: Serrano, Mariana, et al.
Publicado: (2022)

Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
por: Jeon, Chul-Hyo, et al.
Publicado: (2019)

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
por: Lee, Po-Hsin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_svq0tp2frqsdudfdqdt5n5ucpk